Activated protein C (APC) resistance: Considerations about the importance of using the original and modified methods in thrombophilic disease

Thrombosis and Haemostasis

Volumn 84, Issue 1, 2000, Pages 138-139

  Gennari, L ^a   Blanco, A N ^a   Bermejo, E ^a   Salviu, J ^a   Grosso, S ^a   Lazzari, M A ^a  

^a INST DE INVEST HEMATOLOGICAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; LUPUS ANTICOAGULANT;

ACTIVATED PROTEIN C RESISTANCE; ARTERY DISEASE; ATHEROSCLEROSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENE MUTATION; HUMAN; LETTER; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PREGNANCY; PRIORITY JOURNAL; THROMBOPHILIA; THROMBOSIS;

EID: 0033919740     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613983     Document Type: Letter

References (6)